BlueStripes Biotech is a start-up project enrolled in an incubation program from the SATT Aquitaine (Chrysa-Link) in the region of Bordeaux (France) until the end of 2023.
Our goal? Limit the molecular attrition rate in drug development phases that is due to a lack of predictability of adverse effects on the nervous system.
Our solution? We have developed an innovative platform using the zebrafish model for the rapid screening of molecular safety and evaluation of efficacy in early discovery stages. More particularly, we are experts in neurotoxicity and neurotherapeutic efficacy. Our solutions are based on an improvement of the well-known locomotion tests that allows us to provide more sensitive results with high predictability in a faster⌛️ and cost-effective 💸 way!
Our values? 3R compliance, quality and reliability. We have at heart to deliver services meeting the highest quality standards and scientific expertise.
Our services are aimed for the pharmaceutical, cosmetological and chemical industries.
🖐️If you are interested about our technology please contact us at contact@bluestripes-biotech.com, we will be more than happy to discuss further!
Company Details
- Address
- Bordeaux, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Bordeaux
Bluestripes Biotech Questions
Bluestripes Biotech's LinkedIn profile is https://fr.linkedin.com/company/bluestripes-biotech
Bluestripes Biotech's industry is
Biotechnology Research
Bluestripes Biotech's top competitors are
Antabio,
Explicyte,
Doxanano,
Op2 Drugs Sas,
Immunext,
Eden Tech,
Aelis Farma,
Novaptech,
Ysopia Bioscience,
Ableads.
Bluestripes Biotech's categories are Biotechnology Research
